Cover Image

Moving forward to ‘put people first’

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Alice Tseng, Kimberly K. Scarsi, Mona Loutfy
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Clinical Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Community partnership to optimize engagement in research: Reflections on the trans women HIV research initiative
by: Angela Underhill, et al.
Published: (2024)

Inter‐ and intraindividual variability of long‐acting cabotegravir/rilpivirine pharmacokinetics after 1 year of continuous use
by: S. Sunagawa, et al.
Published: (2025)

Innovations in pharmacovigilance studies of medicines in older people
by: Lisa M. Kalisch Ellett, et al.
Published: (2024)

Population pharmacokinetic analysis of doravirine in real‐world people with HIV
by: Paul Thoueille, et al.
Published: (2024)

Exploring new avenues: Psychedelic‐assisted therapy for young people
by: Ioanna Artemis Vamvakopoulou, et al.
Published: (2026)

Medication adherence for people with acquired communication disorders: A systematic review
by: Shauna Bell, et al.
Published: (2024)

Comment on revisiting the association between anticholinergic burden and frailty in people with HIV
by: Yu Wang
Published: (2026)

Lamivudine and tenofovir pharmacokinetic variability in people with HIV in Papua New Guinea
by: Natália Bordin Andriguetti, et al.
Published: (2025)

Association between anticholinergic burden and sleep quality in people living with HIV
by: Maria Mazzitelli, et al.
Published: (2025)

Low‐dose amitriptyline: A potential therapeutic option for chronic pain in older people
by: Takayuki Suga, et al.
Published: (2024)

Co‐design–related approaches in medication safety for people with dementia: A scoping review
by: Zena El‐kadomi, et al.
Published: (2026)

Assessing ChatGPT's capability in understanding and reporting antiretroviral therapy drug–drug interaction effects: Quantitative and qualitative results from the ACCURATE‐DDI study
by: E. Ready, et al.
Published: (2025)

Cost‐effectiveness of first‐line systemic therapies for unresectable hepatocellular carcinoma
by: Dai Lian, et al.
Published: (2024)

Transgender people in clinical trials of drugs and biologics: An analysis of ClinicalTrials.gov from 2007 to 2023
by: Zachary Schonrock, et al.
Published: (2024)

The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta‐analysis
by: Hui Wen Quek, et al.
Published: (2024)

Trends in first‐line monotherapy and combination therapy for hypertension in UK primary care
by: Kyle Johnson, et al.
Published: (2025)

Preliminary efficacy and safety profile of dual histamine blockade on preventing filgrastim‐associated bone pain in breast cancer patients: Randomized controlled trial
by: Mona M. Eltamalawy, et al.
Published: (2025)

Multifactorial attribution for vancomycin‐associated acute kidney injury
by: Yu‐Ling Tseng, et al.
Published: (2026)

Equity and quality use of medicines in people who present to the Psychiatric Alcohol and Non‐Prescription Drug Assessment Unit
by: Jana Stojanova, et al.
Published: (2025)

Saliva monitoring of prednisolone in children with first onset steroid‐sensitive nephrotic syndrome: Is it possible?
by: Floor Veltkamp, et al.
Published: (2024)

Clinical outcomes of switching to dolutegravir/lamivudine dual therapy in people living with HIV: A single‐centre retrospective study
by: D. Yagci‐Caglayik, et al.
Published: (2025)

Estimation of adherence to urate‐lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient‐reported dosing
by: Marcel Schulz, et al.
Published: (2024)

Trust first, concerns second: An international vignette study of older adults' preferences towards deprescribing statins
by: Sarah E. Vordenberg, et al.
Published: (2026)

Best fit framework synthesis of qualitative studies on factors associated with medication nonadherence in people with type 2 diabetes using the COM‐B model
by: Vivien Teo, et al.
Published: (2025)

Effect of carbamazepine on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera estrogen receptor degrader, in healthy adults
by: Hechuan Wang, et al.
Published: (2026)

Pharmacokinetic of ceftazidime‐avibactam in a critically ill patient under high‐volume continuous venovenous haemodiafiltration: A first paediatric case report
by: Charlotte Collignon, et al.
Published: (2024)

Single‐dose pharmacokinetics and safety of ACC017, a novel HIV integrase inhibitor, in healthy adult participants: A first‐in‐human study
by: C. Hu, et al.
Published: (2025)

Effect of oxycodone vs . morphine as first‐line opioid on new persistent opioid use after orthopaedic surgery: A prospective sequential cohort study
by: Eward J. Melis, et al.
Published: (2026)

Neurotoxicity from inordinate valacyclovir dosage in an elderly woman with stage 5 chronic kidney disease
by: Juan A. Vasquez Vasquez, et al.
Published: (2025)

Pharmacometrics analyses and modelling of concentration‐corrected QT interval and concentration‐creatine kinase MB in healthy adults and treatment‐naïve people with HIV‐1 on ainuovirine monotherapy, and combined with lamivudine and tenofovir DF: The pooled analyses of early clinical pharmacology studies
Published: (2024)

Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single‐centre study
by: Gianluca Gazzaniga, et al.
Published: (2026)

A preliminary analysis of the impact of pharmacogenetic variation on bictegravir and dolutegravir concentrations in individuals with HIV and tuberculosis
by: A. Naidoo, et al.
Published: (2025)

Management of serotonin syndrome (toxicity)
by: Angela L. Chiew, et al.
Published: (2024)

Pharmacogenomics in 2023: Big studies, big results, big implications, big responsibilities: Editorial
by: Ann K. Daly, et al.
Published: (2024)

Response to: Letter regarding ‘Management of serotonin syndrome (toxicity)’
by: Angela L. Chiew, et al.
Published: (2025)

GS‐443902 concentrations in peripheral blood mononuclear cells and dried blood spots among pregnant and non‐pregnant women receiving remdesivir for COVID‐19 treatment
by: A. Dunbar, et al.
Published: (2025)

Glial modulators as novel therapeutics for comorbid pain and opioid use disorder
by: Elizabeth K. C. Schwartz, et al.
Published: (2024)

Development of a generalized pharmacokinetic model to characterize clinical pharmacokinetics of monomethyl auristatin E‐based antibody–drug conjugates
by: Hsuan‐Ping Chang, et al.
Published: (2024)

A prospective series of acute rivaroxaban overdose, coagulopathy and bleeding complications (ATOM 11)
by: Katherine Z. Isoardi, et al.
Published: (2026)

Antiviral dose response against CMV infection varies with the timing of treatment initiation
by: L. Sudarsono, et al.
Published: (2025)